Skip to content

Agnikarma and Balamoolghanvati in Avbahuka

Evaluation of Agnikarma and Balamoolghanvati in Avbahuka

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/07/034931
Enrollment
30
Registered
2021-07-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M256- Stiffness of joint, not elsewhereclassified

Interventions

Intervention1: a. balamoolghanvati: 10 patients will be treated with balamoolghanvati 500 mg twice a day for duration of 60 days Control Intervention1: Agnikarma: Agnikarma will be performed on 10 pat

Sponsors

gurukul campus UAU Haridwar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Avbahuka diagnosed according to classical signs and symptoms described in ayurveda as well as modern text. Patient of both sexes within age group 20-60 years.

Exclusion criteria

Exclusion criteria: Patient with history of fracture of affected hand/ dislocation. tuberculosis pregnancy and lactating female diabetes mellitus leprosy congenital anomaly patient in which agnikarma is contraindicated anemia

Design outcomes

Primary

MeasureTime frame
the improvement will be assessed on the basis of 1.Subjective parameters- stiffness tenderness and pain 2. objective parameter- Range of motion by goniometerTimepoint: for subjective parameters- 1,15,30,45,60 days. for objective parameters- 1,30 and 60 days.

Secondary

MeasureTime frame
the improvement will be assessed on the basis of 1.Subjective parameters- stiffness tenderness and pain 2. objective parameter- Range of motion by goniometerTimepoint: 60 days

Countries

India

Contacts

Public ContactPankaj kumar sharma

gurukul campus , UAU, Haridwar

drpankajsharma21@yahoo.com9927067792

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026